Analgesics
|
Anesthetics
|
Anti-Addiction/Substance Abuse Treatment Agents
|
Antibacterials
|
Anticonvulsants
|
Antidementia Agents
|
Antidepressants
|
Antiemetics
|
Antifungals
|
Antigout Agents
|
Antimigraine Agents
|
Antimyasthenic Agents
|
Antimycobacterials
|
Antineoplastics
|
Alkylating Agents
|
Antiandrogens
|
Antiestrogens/Modifiers
|
Antimetabolites
|
Aromatase Inhibitors
|
Immunomodulatory Agents
|
Molecular Target Inhibitors
|
Tagraxofusp
|
Venetoclax
|
Acalabrutinib
|
Ibrutinib
|
Pirtobrutinib
|
Zanubrutinib
|
Abemaciclib
|
Palbociclib [DG:DG01831]
|
Ribociclib [DG:DG02084]
|
Afatinib [DG:DG00717]
|
Dacomitinib [DG:DG01793]
|
Erlotinib [DG:DG00711]
|
Gefitinib
|
Osimertinib
|
Tazemetostat [DG:DG03020]
|
Erdafitinib
|
Futibatinib
|
Infigratinib [DG:DG03062]
|
Pemigatinib
|
Glasdegib [DG:DG02912]
|
Sonidegib [DG:DG01854]
|
Vismodegib
|
Belinostat
|
Panobinostat [DG:DG01403]
|
Romidepsin
|
Vorinostat
|
Ivosidenib
|
Olutasidenib
|
Enasidenib [DG:DG02837]
|
Momelotinib [DG:DG01366]
|
Pacritinib
|
Ruxolitinib [DG:DG00719]
|
Adagrasib
|
Sotorasib
|
Binimetinib
|
Cobimetinib [DG:DG01825]
|
Selumetinib [DG:DG01414]
|
Capmatinib [DG:DG02081]
|
Tepotinib [DG:DG03087]
|
Everolimus
|
Temsirolimus
|
Axitinib
|
Cabozantinib [DG:DG01670]
|
Lenvatinib [DG:DG01362]
|
Neratinib [DG:DG02303]
|
Pazopanib
|
Regorafenib [DG:DG00720]
|
Sorafenib [DG:DG00713]
|
Sunitinib [DG:DG00712]
|
Tivozanib [DG:DG01375]
|
Tucatinib
|
Vandetanib
|
Alectinib [DG:DG01625]
|
Brigatinib
|
Ceritinib
|
Crizotinib
|
D09731 Crizotinib (JAN/USAN/INN)
|
Lorlatinib
|
Asciminib [DG:DG03004]
|
Bosutinib [DG:DG00718]
|
Dasatinib [DG:DG00714]
|
Imatinib [DG:DG00710]
|
Nilotinib [DG:DG00716]
|
Ponatinib [DG:DG00722]
|
Dabrafenib [DG:DG00721]
|
Encorafenib
|
Trametinib [DG:DG00723]
|
Vemurafenib
|
Pexidartinib [DG:DG02960]
|
Fedratinib [DG:DG02968]
|
Gilteritinib [DG:DG01948]
|
Midostaurin
|
Quizartinib [DG:DG01364]
|
Lapatinib [DG:DG00715]
|
Pralsetinib
|
Selpercatinib
|
Selinexor
|
Avapritinib
|
Ripretinib
|
Alpelisib
|
Copanlisib [DG:DG01926]
|
Duvelisib
|
Idelalisib
|
Umbralisib [DG:DG02988]
|
Niraparib [DG:DG03120]
|
Olaparib
|
Rucaparib [DG:DG01864]
|
Talazoparib [DG:DG01865]
|
Bortezomib
|
Ixazomib [DG:DG01269]
|
Carfilzomib
|
Daunorubicin [DG:DG00697]
|
Doxorubicin [DG:DG00696]
|
Epirubicin [DG:DG00698]
|
Etoposide [DG:DG00693]
|
Idarubicin [DG:DG00700]
|
Irinotecan [DG:DG00726]
|
Teniposide
|
Topotecan [DG:DG00725]
|
Valrubicin
|
Entrectinib
|
Larotrectinib [DG:DG02923]
|
Monoclonal Antibody/Antibody-Drug Conjugate
|
Retinoids
|
Antineoplastic Adjuncts/Mitigators
|
Antineoplastics, Other
|
Anti-Obesity Agents
|
Antiparasitics
|
Antiparkinson Agents
|
Antipsychotics
|
Antispasticity Agents
|
Antivirals
|
Anxiolytics
|
Bipolar Agents
|
Blood Glucose Regulators
|
Blood Products and Modifiers
|
Cardiovascular Agents
|
Central Nervous System Agents
|
Contraceptives
|
Dental and Oral Agents
|
Dermatological Agents
|
Electrolytes/Minerals/Metals/Vitamins
|
Gastrointestinal Agents
|
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
|
Genitourinary Agents
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
Hormonal Agents, Suppressant (Pituitary)
|
Hormonal Agents, Suppressant (Thyroid)
|
Immunological Agents
|
Infertility Agents
|
Inflammatory Bowel Disease Agents
|
Metabolic Bone Disease Agents
|
Ophthalmic Agents
|
Otic Agents
|
Respiratory Tract/Pulmonary Agents
|
Sexual Disorder Agents
|
Skeletal Muscle Relaxants
|
Sleep Disorder Agents
|